Basic Information
RNALocate ID: RLID:11001269
RNA Symbol: hsa-miR-197-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-197-3p
RNA ID: miRBase:MIMAT0000227
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23382797
Tissue/Cell Line: Brain tissue
Method: Microarray
Description: We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001554 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001555 Mitochondrion Myotube 27396686
RLID:01001556 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001557 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001558 Nucleus Neural progenitor cells 21363885
RLID:11001264 Exosome Pooled sera 27278097
RLID:11001265 Exosome Primary ovarian tumor cells|Serum 18589210
RLID:11001266 Exosome Peripheral blood mononuclear cells 19002258
RLID:11001267 Exosome B cell line (Raji)|Jurkat-derived T cell line (J77cl20) 21505438
RLID:11001268 Exosome Ovarian follicular fluid 22116803
RLID:11001270 Exosome Plasma 23663360
RLID:11001271 Extracellular vesicle HEK-293T cells 22849433
RLID:11001272 Microvesicle Seminal plasma 23539611
RLID:11001273 Microvesicle Follicular fluid 23666971
RLID-D:11000038 Exosome B lymphoblastoid cells|Endothelial cells
RLID-D:11000306 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-197-3p Oral squamous cell carcinoma MNDR-E-MI-24305
MNDR hsa-miR-197-3p Uterine corpus endometrial carcinoma MNDR-E-MI-24306
MNDR hsa-miR-197-3p Lymphoma MNDR-E-MI-24307
MNDR hsa-miR-197-3p Estrogen-receptor negative breast cancer MNDR-E-MI-24308
MNDR hsa-miR-197-3p Progesterone-receptor negative breast cancer MNDR-E-MI-24309
MNDR hsa-miR-197-3p Her2-receptor positive breast cancer MNDR-E-MI-24310
MNDR hsa-miR-197-3p Anencephaly MNDR-E-MI-24311
MNDR hsa-miR-197-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-24312
MNDR hsa-miR-197-3p Dermatomyositis MNDR-E-MI-24313
MNDR hsa-miR-197-3p Prostate cancer MNDR-E-MI-24314
MNDR hsa-miR-197-3p Gastric cancer MNDR-E-MI-24315
MNDR hsa-miR-197-3p Alzheimer disease MNDR-E-MI-24316
MNDR hsa-miR-197-3p Intracranial aneurysm MNDR-E-MI-24317
MNDR hsa-miR-197-3p Dysautonomia familial MNDR-E-MI-24318
MNDR hsa-miR-197-3p Muscular dystrophy duchenne MNDR-E-MI-24319
MNDR hsa-miR-197-3p Primary biliary cirrhosis MNDR-E-MI-24320
MNDR hsa-miR-197-3p Graves disease MNDR-E-MI-24321
MNDR hsa-miR-197-3p Leukemia MNDR-E-MI-24322
MNDR hsa-miR-197-3p Huntington disease MNDR-E-MI-24323
MNDR hsa-miR-197-3p Chorea MNDR-E-MI-24324
MNDR hsa-miR-197-3p Cardiovascular disease MNDR-E-MI-24325
MNDR hsa-miR-197-3p Moyamoya disease MNDR-E-MI-24326
MNDR hsa-miR-197-3p Uterine fibroid MNDR-E-MI-24327
MNDR hsa-miR-197-3p Lung cancer MNDR-E-MI-24328
MNDR hsa-miR-197-3p Down syndrome MNDR-E-MI-24329
MNDR hsa-miR-197-3p Parkinson disease MNDR-E-MI-24330
MNDR hsa-miR-197-3p Breast cancer MNDR-E-MI-24331
MNDR hsa-miR-197-3p Pancreatic cancer MNDR-E-MI-24332
MNDR hsa-miR-197-3p Melanoma MNDR-E-MI-24333
MNDR hsa-miR-197-3p Rectum adenocarcinoma MNDR-E-MI-24334
MNDR hsa-miR-197-3p Nephroblastoma MNDR-E-MI-24335
MNDR hsa-miR-197-3p Colon cancer MNDR-E-MI-24336
MNDR hsa-miR-197-3p Colon adenocarcinoma MNDR-E-MI-24337
MNDR hsa-miR-197-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-24338
MNDR hsa-miR-197-3p Familial ovarian cancer MNDR-E-MI-24339
MNDR hsa-miR-197-3p Prostate adenocarcinoma MNDR-E-MI-24340
MNDR hsa-miR-197-3p Kidney cancer MNDR-E-MI-24341
MNDR hsa-miR-197-3p Carcinoma ductal breast MNDR-E-MI-24342
MNDR hsa-miR-197-3p Glioblastoma MNDR-E-MI-24343
MNDR hsa-miR-197-3p Astrocytoma MNDR-E-MI-24344
MNDR hsa-miR-197-3p Glioma MNDR-E-MI-24345
MNDR hsa-miR-197-3p Chronic obstructive pulmonary disease MNDR-E-MI-24346
MNDR hsa-miR-197-3p Amyotrophic lateral sclerosis MNDR-E-MI-24347
MNDR hsa-miR-197-3p Epilepsy temporal lobe MNDR-E-MI-24348
MNDR hsa-miR-197-3p Osteosarcoma MNDR-E-MI-24349
MNDR hsa-miR-197-3p Liposarcoma MNDR-E-MI-24350
MNDR hsa-miR-197-3p Coronary artery disease MNDR-E-MI-24351
MNDR hsa-miR-197-3p Inclusion body myositis MNDR-E-MI-24352
MNDR hsa-miR-197-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-24353
MNDR hsa-miR-197-3p Liver cancer MNDR-E-MI-24354
MNDR hsa-miR-197-3p Uterine cancer MNDR-E-MI-24355
MNDR hsa-miR-197-3p Gastric adenocarcinoma MNDR-E-MI-24356
MNDR hsa-miR-197-3p Bone-invasive pituitary adenoma MNDR-E-MI-24357
MNDR hsa-miR-197-3p Lung squamous cell carcinoma MNDR-E-MI-24358
MNDR hsa-miR-197-3p Carcinoma lung non-small-cell MNDR-E-MI-24359
MNDR hsa-miR-197-3p Lung adenocarcinoma MNDR-E-MI-24360
MNDR hsa-miR-197-3p Follicular thyroid carcinoma MNDR-E-MI-24361
MNDR hsa-miR-197-3p Thyroid carcinoma MNDR-E-MI-24362
MNDR hsa-miR-197-3p Pancreatic adenocarcinoma MNDR-E-MI-24363
MNDR hsa-miR-197-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-24364
MNDR hsa-miR-197-3p Kidney renal clear cell carcinoma MNDR-E-MI-24365
MNDR hsa-miR-197-3p Kidney renal papillary cell carcinoma MNDR-E-MI-24366
MNDR hsa-miR-197-3p Clear cell renal cell carcinoma MNDR-E-MI-24367
MNDR hsa-miR-197-3p Cholangiocarcinoma MNDR-E-MI-24368
MNDR hsa-miR-197-3p Esophageal cancer MNDR-E-MI-24369
MNDR hsa-miR-197-3p Head and neck squamous cell carcinoma MNDR-E-MI-24370
MNDR hsa-miR-197-3p Encephalomyelitis MNDR-E-MI-24371
MNDR hsa-miR-197-3p Breast invasive carcinoma MNDR-E-MI-24372
MNDR hsa-miR-197-3p Hepatocellular carcinoma MNDR-E-MI-24373
MNDR hsa-miR-197-3p Familiar ovarian carcinoma MNDR-E-MI-24374
MNDR hsa-miR-197-3p B-cell lymphoma MNDR-E-MI-24375
MNDR hsa-miR-197-3p Rheumatoid arthritis MNDR-E-MI-24376
MNDR hsa-miR-197-3p Neuroblastoma MNDR-E-MI-24377
MNDR hsa-miR-197-3p Barrett's adenocarcinoma MNDR-E-MI-24378
MNDR hsa-miR-197-3p Burkitt lymphoma MNDR-E-MI-24379
MNDR hsa-miR-197-3p Neuromyelitis optica MNDR-E-MI-24380
MNDR hsa-miR-197-3p Psoriasis MNDR-E-MI-24381
MNDR hsa-miR-197-3p Skin cutaneous melanoma MNDR-E-MI-24382
MNDR hsa-miR-197-3p Skin melanoma MNDR-E-MI-24383
MNDR hsa-miR-197-3p Acute myelocytic leukemia MNDR-E-MI-24384
MNDR hsa-miR-197-3p Colorectal cancer MNDR-E-MI-24385
MNDR hsa-miR-197-3p Nasopharynx carcinoma MNDR-E-MI-24386
MNDR hsa-miR-197-3p Acute lymphocytic leukemia MNDR-E-MI-24387
MNDR hsa-miR-197-3p Nasopharyngeal cancer MNDR-E-MI-24388
MNDR hsa-miR-197-3p Hypersomnolence idiopathic MNDR-E-MI-24389
MNDR hsa-miR-197-3p Intracranial hemorrhage hypertensive MNDR-E-MI-24390
MNDR hsa-miR-197-3p Pancreatitis chronic MNDR-E-MI-24391
MNDR hsa-miR-197-3p Barrett's carcinogenesis MNDR-E-MI-24392
MNDR hsa-miR-197-3p Breast cancer her3+ negative MNDR-E-MI-24393
MNDR hsa-miR-197-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-24394
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ACVR1 Homo sapiens RR00038744
TOP